fashion -WSS

fashion

author：fashion 2025-09-27 09:57:39 - browse：48

A nurse prepares to administer chemotherapy treatment. -- Cancer coverage from STAT — Preparing a chemotherapy treatment at Duke Cancer Center in Durham, N.C. Gerry Broome/AP

A young girl, maybe 5 or 6 years old, had come into Yoram Unguru’s clinic with acute lymphoblastic leukemia, the most common of all childhood cancers. One of the drugs needed for treatment was methotrexate. The only problem was that the drug was in short supply.

“Oftentimes we can cure kids of their disease, but we can’t do that without the drugs,” said Unguru, a pediatric hematologist oncologist at Children’s Hospital at Sinai in Baltimore and the Johns Hopkins School of Medicine. “It’s just so, so maddening.”

Methotrexate isn’t the only essential chemotherapy clinicians are having a hard time getting their hands on right now. Two other key chemotherapies, cisplatin and carboplatin, which are also generic injectable drugs, have been in shortage for the last few months. But Unguru didn’t see this particular patient recently or even in the last year. He saw her over a decade ago, when the country was facing a different methotrexate shortage back in 2012.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： A solution to the after

WSS

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Antivenom research: Lessons from HIV applied in search for universal antidote

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

ProMED sees offers of support, but its future remains unclear

Community Health Systems hospitals under DOJ investigation

Hilary expected to bring catastrophic, life

leisure time

fashion

entertainment

Activists slam private health insurers over coverage restrictions

Cancer drug shortages' outsize impact on ovarian cancer patients

How to save PrEP access — and even expand it

Trump cancels press conference intended to dispute Georgia election interference charges

In age of alternative facts, a scholarly course on calling out crap

ProMED sees offers of support, but its future remains unclear

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

As Maui death toll rises, number of missing remains unclear

focus

ActiGraph execs on goal of drug approvals with digital endpoints

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

With competition flaring, obesity drug hits goal in liver disease study

Congress must give Medicare recipients genetic counseling access

R1 RCM gets $5.8 billion buyout offer from private equity firm

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

leisure time

focus

explore

hotspot